Search - tctmd.com

Displaying 321 - 340 of 2033

Sort: Relevancy | Date

Impella RP Mortality Rate No Longer a Concern, FDA Says

News Daily News

Impella RP Mortality Rate No Longer a Concern, FDA Says

December 05, 2022

Real-World TEER Outcomes in Primary MR Make Gains, but Questions Remain

News Conference News PCR London Valves 2022

Real-World TEER Outcomes in Primary MR Make Gains, but Questions Remain

December 01, 2022

Big Gains in Function, QoL With Transcatheter TV Replacement: TRISCEND Registry

News Conference News PCR London Valves 2022

Big Gains in Function, QoL With Transcatheter TV Replacement: TRISCEND Registry

November 28, 2022

SPYRAL HTN-ON MED Trial of Renal Denervation Misses Primary Endpoint

News Conference News AHA 2022

SPYRAL HTN-ON MED Trial of Renal Denervation Misses Primary Endpoint

November 09, 2022

High-Sensitivity Troponin Testing on the Rise in the US, but Still Limited

News Conference News AHA 2022

High-Sensitivity Troponin Testing on the Rise in the US but Still Limited

Michael O'Riordan

November 04, 2022

TRANSCEND: Low-Dose DCB for PAD Still Looking Good at 2 Years

News Conference News VIVA 2022

TRANSCEND: Low-Dose DCB for PAD Still Looking Good at 2 Years

November 03, 2022

More Endpoints, More Problems: FDA Offers Advice for Multi-endpoint Trials

News Daily News

More Endpoints, More Problems: FDA Offers Advice for Multi-endpoint Trials

Michael O'Riordan

October 28, 2022

Novel Machine-Learning Score Can Predict FFR-Defined Ischemia Better Than Visual Stenosis

News Daily News

Novel Machine-Learning Score Can Predict FFR-Defined Ischemia Better Than Visual Stenosis

Yael L. Maxwell

October 25, 2022

US Claims Data Point to Better Survival With Impella vs IABP in High-Risk PCI

News Daily News

US Claims Data Point to Better Survival With Impella vs IABP in High-Risk PCI

October 20, 2022

From Mountains to Meds: A Grassroots Effort Is Restocking Cath Labs in Ukraine

News Features

From Mountains to Meds: A Grassroots Effort Is Restocking Cath Labs in Ukraine

October 18, 2022

No Benefit of LAA Ligation During HeartMate 3 Implantation: MOMENTUM 3

News Conference News HFSA 2022

No Benefit of LAA Ligation During HeartMate 3 Implantation: MOMENTUM 3

Yael L. Maxwell

October 07, 2022

AI-ECG Strategy Identifies Patients at Risk for AF

News Daily News

AI-ECG Strategy Identifies Patients at Risk for AF

September 30, 2022

Initiative Lowers Unnecessary Aspirin Use in Warfarin Users

News Daily News

Initiative Lowers Unnecessary Aspirin Use in Warfarin Users

September 26, 2022

Most Patient-Reported Outcome Measures in CVD Fall Short

News Daily News

Most Patient-Reported Outcome Measures in CVD Fall Short

September 23, 2022

Strengths and Limitations of Patient Reported Outcomes as Major Endpoints in "Modern Era" CV Trials

Presentation TCT 2022

Strengths and Limitations of Patient Reported Outcomes as Major Endpoints in "Modern Era" CV Trials

Presenter: Alexander Iribarne

September 19, 2022

Newer FlexNav Delivery System Improves Placement of Portico TAVI Valve

News Conference News TCT 2022

Newer FlexNav Delivery System Improves Placement of Portico TAVI Valve

September 19, 2022

Expanding the Spectrum of TEER Suitability: Evidence from the EXPAND G4 Post Approval Study

Presentation TCT 2022

Expanding the Spectrum of TEER Suitability: Evidence from the EXPAND G4 Post Approval Study

Presenter: Jason Rogers

September 18, 2022

Amulet, Watchman 2.5 LAAO Devices Provide Comparable 3-Year Outcomes

News Conference News TCT 2022

Amulet, Watchman 2.5 LAAO Devices Provide Comparable 3-Year Outcomes

September 18, 2022

TRILUMINATE Pivotal Trial: First Data Support Safety, Efficacy of TriClip

News Conference News TCT 2022

TRILUMINATE Pivotal Trial: First Data Support Safety, Efficacy of TriClip

September 17, 2022

Dedicated Catheter for Acute PE Shows Promise in IDE Trial

News Conference News TCT 2022

Dedicated Catheter for Acute PE Shows Promise in IDE Trial

September 17, 2022

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.